ArticleOncotarget2016

Octreotide-periplocymarin conjugate prodrug for improving targetability and anti-tumor efficiency: synthesis, in vitro and in vivo evaluation.

Hui-Yun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.